Latest filing published 03 Sept 2020 for Vaccinex, INC., €1,647.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +32.9%Entry US$1,029.00 · Close at T+365 US$1,367.10
- +5.9%Entry US$1,035.30 · Close at T+365 US$1,096.20
- +19.3%Entry US$882.00 · Close at T+365 US$1,052.10
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Scott E. Royer: trading record in brief
All filings by Scott E. Royer on record concern Vaccinex, Inc. The record holds 5 filings, for trades running from 27 December 2018 to 3 September 2020.
No open-market sale appears; the market trades are 4 purchases worth €16k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 1 option exercise.
A typical purchase (the median) is worth €3,739. None of the 4 purchases we analysed coincided with buying by another insider of the same company within 30 days. Looking at 4 purchases old enough to measure, the stock rose over the following 90 days in 100% of cases; the median change was +58.4%. Past outcomes like these are no guarantee of what comes next.
The latest filing, published on 3 September 2020, reports an option exercise of €1,647 in Vaccinex, Inc. The most recent open-market purchase was published on 8 February 2019, 2,831 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Scott E. Royer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 500 shares@ US$3.90100.0% of flowCommon StockSEC:0000891839-20-000256:0
- 275 shares@ US$4.576.2% of flowCommon StockSEC:0000891839-19-000033:0Canonical exit: 7 May 2019 (T+90)
- 1,725 shares@ US$5.0542.8% of flowCommon StockSEC:0000891839-19-000033:1Canonical exit: 8 May 2019 (T+90)
- 1,688 shares@ US$4.3135.4% of flowCommon StockSEC:0000891839-19-000022:0Canonical exit: 15 Apr 2019 (T+90)
- 311 shares@ US$4.156.3% of flowCommon StockSEC:0000891839-18-000122:0Canonical exit: 27 Mar 2019 (T+90)
5 of 5 declarations